Immune Evasion as the Main Challenge for Immunotherapy of Cancer

Affiliations

¹ Department of Clinical Immunology, Medical University of Warsaw, Nowogrodzka 59 Street, 02-006 Warsaw, Poland.
² Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Street, 02-097 Warsaw, Poland.

Editorial

Radoslaw Zagozdzon et al. Cancers (Basel). 2022.

. 2022 Jul 26;14(15):3622.

doi: 10.3390/cancers14153622.

¹ Department of Clinical Immunology, Medical University of Warsaw, Nowogrodzka 59 Street, 02-006 Warsaw, Poland.
² Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Street, 02-097 Warsaw, Poland.

Abstract

Immune evasion is currently considered one of the most prominent hallmarks of cancer [...].

The authors declare no conflict of interest.

1. Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. - DOI - PubMed
1. Burnet F.M. The concept of immunological surveillance. Prog. Exp. Tumor Res. 1970;13:1–27. doi: 10.1159/000386035. - DOI - PubMed
1. Shlyakhtina Y., Moran K.L., Portal M.M. Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution. Cancers. 2021;13:1380. doi: 10.3390/cancers13061380. - DOI - PMC - PubMed
1. Gajewski T.F., Corrales L., Williams J., Horton B., Sivan A., Spranger S. Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment. Adv. Exp. Med. Biol. 2017;1036:19–31. doi: 10.1007/978-3-319-67577-0_2. - DOI - PMC - PubMed
1. Pastorczak A., Domka K., Fidyt K., Poprzeczko M., Firczuk M. Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia. Cancers. 2021;13:1536. doi: 10.3390/cancers13071536. - DOI - PMC - PubMed